Shingo Minatoguchi Selected Research

Alprostadil (Muse)

1/2022	Human Muse cells reduce myocardial infarct size and improve cardiac function without causing arrythmias in a swine model of acute myocardial infarction.
1/2022	Stem cell therapy for acute myocardial infarction - focusing on the comparison between Muse cells and mesenchymal stem cells.
12/2018	Cardiac Rehabilitation With Dynamic Exercise Increases the Number of Muse Cells in the Peripheral Blood of Patients With Heart Disease.
1/2018	Mobilized Muse Cells After Acute Myocardial Infarction Predict Cardiac Function and Remodeling in the Chronic Phase.
1/2018	S1P-S1PR2 Axis Mediates Homing of Muse Cells Into Damaged Heart for Long-Lasting Tissue Repair and Functional Recovery After Acute Myocardial Infarction.
1/2018	Acute Myocardial Infarction, Cardioprotection, and Muse Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shingo Minatoguchi Research Topics

Disease

7	Myocardial Infarction 01/2022 - 01/2018
5	Heart Failure 01/2021 - 12/2018
5	Fibrosis (Cirrhosis) 07/2020 - 01/2015
4	Hypertension (High Blood Pressure) 07/2020 - 01/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2017
3	Left Ventricular Dysfunction 01/2022 - 01/2018
3	Infarction (Infarctions) 01/2022 - 12/2017
3	Heart Diseases (Heart Disease) 01/2019 - 01/2018
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 01/2018
2	Hypertrophy 10/2019 - 01/2019
2	Chronic Renal Insufficiency 04/2019 - 12/2018
1	Acute Coronary Syndrome 01/2022
1	Hematologic Diseases (Blood Diseases) 01/2022
1	Diabetic Cardiomyopathies 01/2021
1	Sclerosis 07/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Diabetes Mellitus 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Body Weight (Weight, Body) 12/2018
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018
1	Heart Valve Diseases (Valvular Heart Disease) 01/2018
1	Angina Pectoris 01/2018
1	Reperfusion Injury 12/2017
1	Atrial Fibrillation 09/2013

Drug/Important Bio-Agent (IBA)

6	Alprostadil (Muse)FDA LinkGeneric 01/2022 - 01/2018
5	SaltsIBA 07/2020 - 01/2015
3	Prorenin ReceptorIBA 07/2020 - 01/2015
2	CreatinineIBA 07/2020 - 12/2018
2	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2019 - 12/2017
2	Therapeutic UsesIBA 04/2019 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019 - 12/2017
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2018
1	Troponin IIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	GlycogenIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2020
1	GlucosidasesIBA 11/2019
1	miglitol (Glyset)FDA Link 11/2019
1	Carnitine (L-Carnitine)FDA LinkGeneric 10/2019
1	Peptides (Polypeptides)IBA 04/2019
1	Sarcoglycans (beta Sarcoglycan)IBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Furosemide (Lasix)FDA LinkGeneric 12/2018
1	Cystatin CIBA 12/2018
1	Tolvaptan FDA Link 12/2018
1	ElectrolytesIBA 12/2018
1	Angiotensin IIIBA 11/2018
1	azilsartanIBA 11/2018
1	alogliptinIBA 12/2017
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 12/2017
1	exendin (9-39)IBA 12/2017
1	Glucagon-Like Peptide-1 ReceptorIBA 12/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2017
1	ReninIBA 01/2015

Therapy/Procedure

2	Cardiac Rehabilitation 01/2022 - 12/2018
2	Therapeutics 01/2022 - 01/2018
1	Percutaneous Coronary Intervention 01/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022
1	Renal Dialysis (Hemodialysis) 10/2019
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 01/2017
1	Catheter Ablation 09/2013